Latest News about BMRN
Recent news which mentions BMRN
BioMarin Receives European Commission's Conditional Marketing Authorization For Gene Therapy Candidate
August 24, 2022
Tickers
BMRN
From Benzinga
What's Next in Pfizer's M&A Ramp-Up?
August 20, 2022
From Motley Fool
Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart
August 09, 2022
Tickers
BMRN
From Benzinga
From Benzinga
From MarketWatch
7 Undervalued Biotech Stocks to Buy Before They Boom
July 25, 2022
From InvestorPlace
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Monday
April 25, 2022
From Benzinga
From Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
From InvestorPlace
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
BioMarin Clocks Flat Q4 Sales Despite Erosion oF US Kuvan Market
February 24, 2022
From Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
February 18, 2022
Tickers
BMRN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.